N. Beschorner

SERF deletion modifies amyloid aggregation in a mouse model of Alzheimer’s disease

H. Fuchs, W. Wurst, M. Jucker, 2022, bioRxiv.

Pretargeted imaging beyond the blood–brain barrier

M. Nedergaard, G. Knudsen, Gitte Moos Knudsen, 2022, RSC medicinal chemistry.

Pretargeted Imaging beyond the Blood–Brain Barrier—Utopia or Feasible?

M. Nedergaard, G. Knudsen, D. Sehlin, 2022, Pharmaceuticals.

Brain deletion of Serf2 shifts amyloid conformation in a mouse model

M. Jucker, W. Hogewerf, A. de Bruin, 2021 .

Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease

Nick C Fox, K. Blennow, B. Ghetti, 2017, Proceedings of the National Academy of Sciences.

Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life

P. Weinreb, M. Staufenbiel, J. Stavenhagen, 2020, Nature Neuroscience.

Deletion of SERF2 in mice delays embryonic development and alters amyloid deposit structure in the brain

H. Fuchs, W. Wurst, W. Hogewerf, 2023, Life Science Alliance.

An in vivo Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates

C. Svarer, G. Knudsen, S. Lehel, 2022, Frontiers in Neuroscience.

An in vivo pig model for testing novel PET radioligands targeting cerebral protein aggregates

C. Svarer, G. Knudsen, S. Lehel, 2022, bioRxiv.

Early Aβ reduction prevents progression of cerebral amyloid angiopathy

H. Dodt, N. Jährling, M. Staufenbiel, 2019, Annals of neurology.

A SPECT-based method for dynamic imaging of the glymphatic system in rats

M. Nedergaard, Y. Mori, M. Rosenholm, 2023, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.